- Home
- CYTO vs SXTP Comparison
CYTO vs SXTP Comparison
Compare CYTO & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTO
- SXTP
- Stock Information
- Founded
- CYTO 2003
- SXTP 2010
- Country
- CYTO Bermuda
- SXTP United States
- Employees
- CYTO N/A
- SXTP N/A
- Industry
- CYTO Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- CYTO Health Care
- SXTP Health Care
- Exchange
- CYTO Nasdaq
- SXTP Nasdaq
- Market Cap
- CYTO 2.0M
- SXTP 1.6M
- IPO Year
- CYTO N/A
- SXTP 2023
- Fundamental
- Price
- CYTO $0.41
- SXTP $1.38
- Analyst Decision
- CYTO
- SXTP Hold
- Analyst Count
- CYTO 0
- SXTP 1
- Target Price
- CYTO N/A
- SXTP N/A
- AVG Volume (30 Days)
- CYTO 182.2K
- SXTP 712.1K
- Earning Date
- CYTO 09-24-2024
- SXTP 11-14-2024
- Dividend Yield
- CYTO N/A
- SXTP N/A
- EPS Growth
- CYTO N/A
- SXTP N/A
- EPS
- CYTO N/A
- SXTP N/A
- Revenue
- CYTO N/A
- SXTP $462,612.00
- Revenue This Year
- CYTO N/A
- SXTP $267.05
- Revenue Next Year
- CYTO N/A
- SXTP $181.82
- P/E Ratio
- CYTO N/A
- SXTP N/A
- Revenue Growth
- CYTO N/A
- SXTP 128.99
- 52 Week Low
- CYTO $0.40
- SXTP $0.70
- 52 Week High
- CYTO $3.60
- SXTP $18.36
- Technical
- Relative Strength Index (RSI)
- CYTO 43.48
- SXTP 52.58
- Support Level
- CYTO $0.40
- SXTP $1.35
- Resistance Level
- CYTO $0.58
- SXTP $1.74
- Average True Range (ATR)
- CYTO 0.06
- SXTP 0.28
- MACD
- CYTO 0.00
- SXTP 0.01
- Stochastic Oscillator
- CYTO 17.14
- SXTP 26.00
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.